| |
| |
SPOT ON
|
| |
Antidepressant drugs: opinion of the professional associations
Resistance to oseltamivir (TAMIFLU)
|
| |
| |
NEW ON THE MARKET
|
| |
Omalizumab (XOLAIR) for allergic asthma
|
| |
| |
THERAPIES FROM A CRITICAL VIEW POINT
|
| |
Antibiotics for atherosclerosis: no benefit - but harmful?
Critical ischemia of the lower limbs: bypass or angioplasty?
|
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
Misleading labelling of drugs
Biologicals for psoriasis
|
| |
| |
QUALITY CHECK
|
| |
Capsule-preparations with 50 mg doxepine (e.g. SINQUAN)
|
| |
| |
IN BRIEF
|
| |
Finally: no beta-carotene for smokers
Sweetener aspartame carcinogenic?
|
| |
| |
CURRENT ADR NETWORK REPORT
|
 |
Ketoacidosis with ziprasidone (ZELDOX)
|
| |
| |
SIDE EFFECTS
|
| |
Macular edema with glitazones
Acid blocking agents and clostridium infections
|
| |